Your browser doesn't support javascript.
loading
Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment.
Lüke, Florian; Blazquez, Raquel; Yamaci, Rezan Fahrioglu; Lu, Xin; Pregler, Benedikt; Hannus, Stefan; Menhart, Karin; Hellwig, Dirk; Wester, Hans-Jürgen; Kropf, Saskia; Heudobler, Daniel; Grosse, Jirka; Moosbauer, Jutta; Hutterer, Markus; Hau, Peter; Riemenschneider, Markus J; Bayerlová, Michaela; Bleckmann, Annalen; Polzer, Bernhard; Beißbarth, Tim; Klein, Christoph A; Pukrop, Tobias.
Afiliação
  • Lüke F; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Blazquez R; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Yamaci RF; Chair of Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
  • Lu X; Chair of Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
  • Pregler B; Institute of Radiology, University Hospital Regensburg, Regensburg, Germany.
  • Hannus S; Intana Bioscience GmbH, Martinsried, Germany.
  • Menhart K; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Hellwig D; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Wester HJ; Chair of Pharmaceutical Radiochemistry, Technische Universität München, Munich, Germany.
  • Kropf S; SCINTOMICS GmbH, Fuerstenfeldbruck, Germany.
  • Heudobler D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Grosse J; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Moosbauer J; Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
  • Hutterer M; Department of Neurology, University Hospital Regensburg, Regensburg, Germany.
  • Hau P; Wilhelm Sander-Neurooncology Unit, University Hospital Regensburg, Regensburg, Germany.
  • Riemenschneider MJ; Department of Neurology 1, NeuroMed Campus, Kepler University Hospital Linz, Linz, Austria.
  • Bayerlová M; Department of Neurology, University Hospital Regensburg, Regensburg, Germany.
  • Bleckmann A; Wilhelm Sander-Neurooncology Unit, University Hospital Regensburg, Regensburg, Germany.
  • Polzer B; Department of Neuropathology, University Hospital Regensburg, Regensburg, Germany.
  • Beißbarth T; University Medical Center Göttingen, Department of Medical Statistics, Göttingen, Germany.
  • Klein CA; University Medical Center Göttingen, Department of Medical Statistics, Göttingen, Germany.
  • Pukrop T; University Medical Center Göttingen, Department of Hematology and Oncology, Göttingen, Germany.
Oncotarget ; 9(27): 18844-18857, 2018 Apr 10.
Article em En | MEDLINE | ID: mdl-29721166

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha